These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31313376)

  • 21. Controlling the false-discovery rate when identifying the subgroup benefiting from treatment.
    Schnell PM
    Clin Trials; 2023 Aug; 20(4):394-404. PubMed ID: 37122134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of false discovery rate using sequential permutation p-values.
    Bancroft T; Du C; Nettleton D
    Biometrics; 2013 Mar; 69(1):1-7. PubMed ID: 23379645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonparametric method to detect increased frequencies of adverse drug reactions over time.
    Heimann G; Belleli R; Kerman J; Fisch R; Kahn J; Behr S; Berlin C
    Stat Med; 2018 Apr; 37(9):1491-1514. PubMed ID: 29322542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A classification approach for DNA methylation profiling with bisulfite next-generation sequencing data.
    Cheng L; Zhu Y
    Bioinformatics; 2014 Jan; 30(2):172-9. PubMed ID: 24273245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study.
    Ahmed I; Thiessard F; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
    Clin Pharmacol Ther; 2010 Oct; 88(4):492-8. PubMed ID: 20811349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of text processing methods in social media-based signal detection.
    Gavrielov-Yusim N; Kürzinger ML; Nishikawa C; Pan C; Pouget J; Epstein LB; Golant Y; Tcherny-Lessenot S; Lin S; Hamelin B; Juhaeri J
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1309-1317. PubMed ID: 31392844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size calculations for controlling the distribution of false discovery proportion in microarray experiments.
    Oura T; Matsui S; Kawakami K
    Biostatistics; 2009 Oct; 10(4):694-705. PubMed ID: 19628638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical issues in the analysis of adverse events in time-to-event data.
    Allignol A; Beyersmann J; Schmoor C
    Pharm Stat; 2016 Jul; 15(4):297-305. PubMed ID: 26929180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A note on using permutation-based false discovery rate estimates to compare different analysis methods for microarray data.
    Xie Y; Pan W; Khodursky AB
    Bioinformatics; 2005 Dec; 21(23):4280-8. PubMed ID: 16188930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridging the False Discovery Gap.
    Ebadi A; Freestone J; Noble WS; Keich U
    J Proteome Res; 2023 Jul; 22(7):2172-2178. PubMed ID: 37261867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More Specific Signal Detection in Functional Magnetic Resonance Imaging by False Discovery Rate Control for Hierarchically Structured Systems of Hypotheses.
    Schildknecht K; Tabelow K; Dickhaus T
    PLoS One; 2016; 11(2):e0149016. PubMed ID: 26914144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-Scale Simultaneous Testing of Cross-Covariance Matrices with Applications to PheWAS.
    Cai T; Cai TT; Liao K; Liu W
    Stat Sin; 2019 Apr; 29(2):983-1005. PubMed ID: 31889766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process.
    Quan H; Ma Y; Zheng Y; Cho M; Lorenzato C; Hecquet C
    Pharm Stat; 2015; 14(3):161-71. PubMed ID: 25612310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False discovery rate estimation for large-scale homogeneous discrete p-values.
    Liang K
    Biometrics; 2016 Jun; 72(2):639-48. PubMed ID: 26492596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical detection of EEG synchrony using empirical bayesian inference.
    Singh AK; Asoh H; Takeda Y; Phillips S
    PLoS One; 2015; 10(3):e0121795. PubMed ID: 25822617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A statistical method for the conservative adjustment of false discovery rate (q-value).
    Lai Y
    BMC Bioinformatics; 2017 Mar; 18(Suppl 3):69. PubMed ID: 28361675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resampling-based empirical Bayes multiple testing procedures for controlling generalized tail probability and expected value error rates: focus on the false discovery rate and simulation study.
    Dudoit S; Gilbert HN; van der Laan MJ
    Biom J; 2008 Oct; 50(5):716-44. PubMed ID: 18932138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.